1. No cash (that we know)

2. Path tbd with BTD (there will be a path forward)

3. Will need cash for whichever path forward is chosen

4. Don has said a partner is needed for path forward (cash/resources/credibility benefits)

5. Don has said there is no shortage of interest, or cash available

There is no reason to "sit" on this technology ... Time is money, and patent life.

Logic dictates we should learn of a deal or partnership arrangement of some type sometime soon, perhaps once we get more feedback from regulatory bodies around the world (FDA/EMA/Asia/Etc), perhaps even another BTD(?), to which applications have been made, and clarity from the various bodies on next steps toward NDA ... ?

Since there is no apparent RVX interest or effort in promoting and pumping up the stock to the public, I just don't see any other "real" likelihood other than collaborative partnering and/or a buyout sometime pretty soon, for moving this project down the road. Even a collaborative partnering deal in the short term, as a prelude to buy out down the road (with "valuable" milestones), should do wonders for the stock, ... with a BP backing, financing, partnering, and positioning for a sale/buyout down the road.

Unless something startling and completely unexpected happens with regulatory or a current non-BP partner, it is hard for me to see anything meaningful happen with this stiock. I believe (hope) some good things will happen in H1, because time's-a-wastin' ... 

That's the way it looks to me ... but jmho ... and yeah, I know, I am an "echo chamber" about this situation and my thoughts/opinions lol :)